首页> 美国卫生研究院文献>Frontiers in Microbiology >Strategies and molecular tools to fight antimicrobial resistance: resistome transcriptome and antimicrobial peptides
【2h】

Strategies and molecular tools to fight antimicrobial resistance: resistome transcriptome and antimicrobial peptides

机译:对抗抗菌素耐药性的策略和分子工具:耐药组转录组和抗菌肽

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The increasing number of antibiotic resistant bacteria motivates prospective research toward discovery of new antimicrobial active substances. There are, however, controversies concerning the cost-effectiveness of such research with regards to the description of new substances with novel cellular interactions, or description of new uses of existing substances to overcome resistance. Although examination of bacteria isolated from remote locations with limited exposure to humans has revealed an absence of antibiotic resistance genes, it is accepted that these genes were both abundant and diverse in ancient living organisms, as detected in DNA recovered from Pleistocene deposits (30,000 years ago). Indeed, even before the first clinical use of antibiotics more than 60 years ago, resistant organisms had been isolated. Bacteria can exhibit different strategies for resistance against antibiotics. New genetic information may lead to the modification of protein structure affecting the antibiotic carriage into the cell, enzymatic inactivation of drugs, or even modification of cellular structure interfering in the drug-bacteria interaction. There are still plenty of new genes out there in the environment that can be appropriated by putative pathogenic bacteria to resist antimicrobial agents. On the other hand, there are several natural compounds with antibiotic activity that may be used to oppose them. Antimicrobial peptides (AMPs) are molecules which are wide-spread in all forms of life, from multi-cellular organisms to bacterial cells used to interfere with microbial growth. Several AMPs have been shown to be effective against multi-drug resistant bacteria and have low propensity to resistance development, probably due to their unique mode of action, different from well-known antimicrobial drugs. These substances may interact in different ways with bacterial cell membrane, protein synthesis, protein modulation, and protein folding. The analysis of bacterial transcriptome may contribute to the understanding of microbial strategies under different environmental stresses and allows the understanding of their interaction with novel AMPs.
机译:越来越多的抗生素抗性细菌激发了前瞻性研究,以发现新的抗菌活性物质。然而,关于这种研究的成本效益方面存在争议,涉及具有新型细胞相互作用的新物质的描述或现有物质克服抗性的新用途的描述。尽管对从偏远地区暴露于有限人类的细菌进行的检查表明没有抗生素抗性基因,但人们公认,在古代活生物体中,这些基因既丰富又多样,如从更新世沉积物中回收的DNA所检测到的(30,000年前) )。确实,甚至在60多年前首次临床使用抗生素之前,就已经分离出耐药菌。细菌可以表现出不同的抗药性策略。新的遗传信息可能导致蛋白质结构的改变,从而影响抗生素向细胞中的运输,药物的酶失活,甚至导致干扰药物-细菌相互作用的细胞结构的改变。在环境中仍然存在大量新基因,推定的病原细菌可以利用这些新基因来抵抗抗菌剂。另一方面,有几种具有抗生素活性的天然化合物可以用来对抗它们。抗菌肽(AMPs)是在各种生命中广泛传播的分子,从多细胞生物到用来干扰微生物生长的细菌细胞。几种AMP已显示对多药耐药细菌有效,并且对耐药性的发展倾向较低,这可能是由于其与已知的抗菌药物不同的独特作用方式所致。这些物质可能以不同的方式与细菌细胞膜,蛋白质合成,蛋白质调节和蛋白质折叠相互作用。细菌转录组的分析可能有助于理解不同环境压力下的微生物策略,并有助于理解它们与新型AMP的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号